When you stop GLP-1 medications, the patients appetite returns, often with a vengeance
- Mejora el estado de nimo: puede impactar positivamente el estado de nimo y el bienestar general
The gastrointestinal effects, including nausea, vomiting, diarrhea, and constipation , affect roughly 40-50% of users at therapeutic doses
These drugs hold the potential to help address what continues to be an increasing obesity problem in the US
Beth Czerwony MS, RD, CSOWM, LD is a Clinical Registered Dietitian with the Cleveland Clinics Center for Human Nutrition since 2007
Proteins 12 , 13401348 (2020)